3 Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Combination Therapy for Colorectal Cancer (SCOT): an International, Randomised, Phase 3, Non-Inferiority Trial Timothy J. Iveson , Rachel S. Kerr , Mark P. Saunders , Jim Cassidy , Niels Henrik Hollander , Josep Tabernero , Andrew Haydon , Bengt Glimelius , Andrea Harkin , Karen Allan , John McQueen , Claire Scudder , Kathleen Anne Boyd , Andrew Briggs , Ashita Waterston , Louise Medley , Charles Wilson , Richard Ellis , Sharadah Essapen , Amandeep S. Dhadda , Mark Harrison , Stephen Falk , Sherif Raouf , Charlotte Rees , Rene K. Olesen , David Propper , John Bridgewater , Ashraf Azzabi , David Farrugia , Andrew Webb , David Cunningham , Tamas Hickish , Andrew Weaver , Simon Gollins , Harpreet S. Wasan , James Paul The Lancet Oncology（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
